Global PeptideTherapeutics Market is predicted to reach USD 48.04 billion by 2025 owing to rise in demand for efficient & speedy treatment of cancer and other lifestyle-related disorders. Peptides are the naturally occurring biological molecules that are used in drugs to improve the patient’s medical condition. They are highly safe and effective due to which they are widely accepted by physicians and patients for treating several ailments.
In
the medical practice, they are ideal for diabetes, infectious diseases, several
type of cancers, cardiovascular and other medical conditions. Peptides are
highly modifiable and versatile in comparison to other drugs, which make them
highly profitable to sponsors. Due to their feature of versatility, they are
used in multiple medical conditions that leads to higher penetration of peptide
therapeutics industry. Apart from therapeutics effects, the market is also
gaining attraction due to comparatively easy marketing approval and
familiarity.
Along
with the growing prevalence of cardiovascular disorders and cancers, the
increasing research & development activities and rich peptide therapeutics
pipeline are predicted to support the growth of the market in near future. The
patent expiration of various peptide drugs in future is expected to create
ample opportunities for the market contributing to its growth at a significant
rate.
Request Sample Copy of This Market Research @
https://www.millioninsights.com/industry-reports/peptide-therapeutics-market/request-sample
Peptide
therapeutics have application in CNS (Central Nervous System) disorders and
respiratory disorders due to features like safe, efficiency and versatility.
Advanced research & development facilities and new peptide developments by
pharma companies are driving the demand for reasonably priced peptide
therapeutics.
Nevertheless,
the large scale production of peptide with increasing complexities of peptides
is a major challenge for peptide therapeutics market. The development of
multifunctional peptides and rise in number of collaboration for the progress
of peptide conjugates are currently ruling the market.
Latest
advances in peptide synthesis technology is projected to be the key driver for
the growth of peptide therapeutics industry. From among the different methods
of peptide synthesis, enzymatic and chemical synthesis are important. This
technology has integrated structure-activity relationships (SARs) and analog
generation to increase bioavailability, increase safety & efficacy of
drugs, impart protease resistance, reduce adverse effects, and develop
formulations.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/peptide-therapeutics-market
The
other driving factor of the market is the shift towards unexploited market. The
market is witnessing several vendors focusing on developing economies due to
presence of large population groups and clinical trial subjects. Factors like
presence of lenient regulatory guidelines, skilled labor, limited market
competition, and low manufacturing costs will encourage vendors to shift their
manufacturing processes to the developing economies.
Peptide
therapeutics market is categorized on the basis of application, technology,
route of administration, molecule type, API peptide type, and geography. On the
basis of application, the market is divided into Cancer, Metabolic, CVD,
Respiratory, GIT, Anti-infective, Dermatology, CNS, Renal, etc. In terms of
route of administration, the market is segmented as Parenteral, Oral, etc.
On
the basis of type, peptide therapeutics industry is divided into Innovative and
Generic. On the basis of technology, the market is classified into Liquid
Phase, Solid Phase, and Hybrid Phase. Type of Molecule is classified into
Vasopressin, Somatostatin, Calcitonin, Immunopeptide, Natriuretic, and others.
On the basis of API Peptide Type, the market is divided into In-house, and CMO
(contract manufacturing organization).
Geographically,
peptide therapeutics market is segmented as North America, Latin America,
Europe, Asia Pacific, and Middle East & Africa. North America and Latin
America are predicted to hold larger share of the market owing to the rising
incidences of cancer and other life-style related disorders.
The
key peptide therapeutics industry players comprise AstraZeneca plc, Amgen Inc.,
Eli Lilly and Company, Sanofi, CordenPharma International GmbH, Teva
Pharmaceutical Industries Ltd., Novartis AG, Ipsen S.A., Lonza Group Ltd.,
Merck & Co. Inc., F. Hoffmann-La Roche AG, Bachem Holding AG, PolyPeptide
Group and Novo Nordisk A/S.
Market
Segment:
Peptide
Therapeutics, Application Outlook (Revenue, USD Million; 2014 - 2025)
• Cancers
• Metabolic
• Cardiovascular Disorder
• Respiratory
• GIT
• Antiinfection
• Pain
• Dermatology
• CNS
• Renal
• Others
Comments
Post a Comment